A serological switching from anti-dsDNA to anti-Sm antibodies coincided with severe clinical manifestations of systemic lupus erythematosus (hemophagocytosis,profundus and psychosis)

Riemekasten G , Hahn BH . Key autoantigens in SLE . Rheumatology 2005; 44: 975–982 .

Tan EM , Cohen AS , Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus . Arthritis Rheum 1982; 25: 1271–1277 .

Harley JB , Sestak AL , Willis LG , Fu SM , Hansen JA , Reichlin M . A model for disease heterogeneity in systemic lupus erythematosus. Relationships between histocompatibility antigens, autoantibodies, and lymphopenia or renal disease . Arthritis Rheum 1989; 32: 826–836 .

Winfield JB , Brunner CM , Koffler D . Serologic studies in patients with systemic lupus erythematosus and central nervous system dysfunction . Arthritis Rheum 1978; 21: 289–294 .

Vlachoyiannopoulos PG , Karassa FB , Karakostas KX , Drosos AA , Moutsopoulos HM . Systemic lupus erythematosus in Greece. Clinical features, evolution and outcome: a descriptive analysis of 292 patients . Lupus 1993; 2: 303–312 .

Reveille JD. Predictive value of autoantibodies for activity of systemic lupus erythematosus . Lupus 2004; 13: 290–297 .

To CH , Petri M . Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus? Arthritis Rheum 2005; 52: 4003–4010 .

Kawashiri S , Nakamura H , Kawakami et al. Emergence of Epstein–Barr virus-associated haemophagocytic syndrome upon treatment of systemic lupus erythematosus . Lupus 2006; 15: 51–53 .

Husebye ES , Sthoeger ZM , Dayan M et al. Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus . Ann Rheum Dis 2005; 64: 1210–1213 .

Bonfa E , Golombek SJ , Kaufman LD et al. Association between lupus psychosis and anti-ribosomal P protein antibodies . N Engl J Med 1987; 317: 265–271 .

Bluestein HG , Williams GW , Steinberg AD . Cerebrospinal fluid anti-bodies to neuronal cells: association with neuropsychiatric manifestations of systemic lupus erythematosus . Am J Med 1981; 70: 240–246 .

Saeki Y , Ohshima S , Kurimoto I , Miura H , Suemura M . Maintaining remission of lupus erythematosus profundus (LEP) with cyclosporin A . Lupus 2000; 9: 390–392 .

Meyer O , Aeschlimann A , Bourgeois P , Kahn MF . Longitudinal immunoblotting variations of auto-antibody reactivity of patients with systemic lupus erythematosus . Autoimmunity 1990; 7: 23–31 .

Reichlin M , Mattioli M . Correlation of a precipitin reaction to an RNAprotein antigen and a low prevalence of nephritis in patients with systemic lupus erythematosus . N Engl J Med 1972; 286: 908–911 .

James JA , Gross T , Scofield RH , Harley JH . Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B'-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity . J Exp Med 1995; 181: 453–461 .

James JA , Harley JB . A model of peptide-induced lupus autoimmune B cell epitope spreading is strain specific and is not H-2 restricted in mice . J Immunol 1998; 160: 502–508 .

Mason LJ , Timothy LM , Isenberg DA , Kalsi JK . Immunization with a peptide of Sm B/B' results in limited epitope spreading but not autoimmune disease . J Immunol 1999; 162: 5099–5105 .